iotrolan has been researched along with Hypertension in 2 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurabayashi, T | 1 |
| Ida, M | 1 |
| Fukayama, H | 1 |
| Ohbayashi, N | 1 |
| Yoshino, N | 1 |
| Sasaki, T | 1 |
| Lasser, EC | 1 |
2 other studies available for iotrolan and Hypertension
| Article | Year |
|---|---|
Adverse reactions to nonionic iodine in contrast-enhanced computed tomography: usefulness of monitoring vital signs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Child; Contrast Media; Drug Evaluation; | 1998 |
The multipotential pseudoantigenicity of X-ray contrast media. Pseudoantigen excess may downregulate the release of hypotensive mediators.
Topics: Animals; Antigen-Antibody Reactions; Antigens; Blood Pressure; Contrast Media; Histamine Release; Hy | 2000 |